Citation Impact
Citing Papers
Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant
2011
Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors
2005
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease
2007
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation
2015
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets
2015
Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome
2010
Antinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology
1989 Standout
Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT
2011
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
HLA class I supertypes: a revised and updated classification
2008
Fabrication and Characterization of Ultrahigh‐Volume‐ Fraction Aligned Carbon Nanotube–Polymer Composites
2008
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
Partially Mismatched Transplantation and Human Leukocyte Antigen Donor-Specific Antibodies
2013
Vascular disorders of the liver # †
2008 Standout
Allogeneic Transplantation for the Elderly Patient With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
2006
Acceptable Donor-Specific Antibody Levels Allowing for Successful Deceased and Living Donor Kidney Transplantation After Desensitization Therapy
2008
Systemic Lupus Erythematosus
2011 Standout
Biology and management of relapsed acute myeloid leukaemia
2005
Type 1 diabetes
2013 Standout
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus
2000
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
1990 Standout
Gene Map of the HLA Region, Graves’ Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation
2015
Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes
2011
HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk
2008
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning
2004
Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry
2013
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
2006
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
2005
Preparation and modification of carbon nanotubes: Review of recent advances and applications in catalysis and sensing
2008
Platelet Activation and Binding of Complement Components to Platelets Induced by Immune Complexes
1994 StandoutNobel
Donor HLA-specific Abs: to BMT or not to BMT?
2015
Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia
2005
Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double-blind randomized clinical trial
1989
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities
2017
Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies
2008
Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia
2005
Dispersion and functionalization of carbon nanotubes for polymer-based nanocomposites: A review
2010 Standout
Immune Complexes in Thrombocytopenic Patients: Cause or Effect?
1980
Regulatory T Cells and Human Disease
2020 StandoutNobel
Acute Myeloid Leukemia
2015 Standout
Free and forced vibrations of functionally graded polymer composite plates reinforced with graphene nanoplatelets
2016 Standout
Immune Complexes in the Rheumatic Diseases
1987
Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia: A Report From the Cooperative German Transplant Study Group
2008
Desensitization for solid organ and hematopoietic stem cell transplantation
2014
Immunoadsorption for Removal of a and B Blood-Group Antibodies
1981 StandoutNobel
Nanomaterial-based Electrochemical Biosensors
2022
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
2006
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
AUTOIMMUNE THYROIDITIS: A CONDITION RELATED TO A DECREASE IN T‐SUPPRESSOR CELLS
1981
Cancer treatment and survivorship statistics, 2016
2016 Standout
Carbon nanotube–polymer composites: Chemistry, processing, mechanical and electrical properties
2009 Standout
Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders
2012
Geometric Deep Learning: Going beyond Euclidean data
2017 Standout
Metal-Free Catalysts for Oxygen Reduction Reaction
2015 Standout
A perspective on the selection of unrelated donors and cord blood units for transplantation
2012
Immunology of Autoimmune Thyroid Diseases
1982 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Urinary excretion of sialic acid‐containing saccharides in systemic lupus erythematosus
1981
In silicogrouping of peptide/HLA class I complexes using structural interaction characteristics
2006
EXTRACORPOREAL IMMUNOADSORPTION: INITIAL EXPERIENCE IN HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS
1979
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
1984 Standout
Recent Advances in Ultrathin Two-Dimensional Nanomaterials
2017 Standout
Recent advances in carbon-based polymer nanocomposites for electromagnetic interference shielding
2019 Standout
Immune complexes in human diseases: a review.
1980
The Biology and Detection of Immune Complexes
1980
Carbon nanotube reinforced metal matrix composites - a review
2010
THE PHENOMENON OF THE ACUTE PHASE RESPONSE*
1982 Standout
The price of immunotherapy
1981
High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis
2013
A review on the production of metal matrix composites through stir casting – Furnace design, properties, challenges, and research opportunities
2019 Standout
Mechanical model to evaluate the effect of the dispersion in nanocomposites
2007
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
1981 Standout
Studies on the Specificity and Clinical Correlation of Antiribosomal Antibodies in Systemic Lupus Erythematosus Sera
1979
Works of Pedro Cano being referenced
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation
2011
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT
2009
High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem-Cell Transplantation
2009
DP reactive antibody in a zero mismatch renal transplant pair
2007
Common and Well-Documented HLA Alleles
2007
A geometric study of the amino acid sequence of class I HLA molecules
1998
Circulating immune complexes in systemic lupus erythematosus.
1977
Circulating immune complexes in patients with atopic allergy
1977
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years
2003
Influence of Allele Level HLA Typing on Unrelated Donor (UD) Transplantation for High Risk Myeloid Leukemias.
2005
Immune Complexes in Human Melanoma: A Consequence of Deranged Immune Regulation
1976
Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation
2013
The Clinical Significance of Matching for Alleles at the Low Expression HLA Loci DP, DQ and DRB3/4/5 in Unrelated Hematopoietic Stem Cell Transplantation
2008
Immune reactions in patients with Graves' disease
1978
COMPLICATIONS OF CANCER IMMUNOTHERAPY WITH LEVAMISOLE
1977
Mechanical Characterization of Carbon Nanotube Composite Materials
2005
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease
2009